GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition – Hagens Berman

▤ Summary

GeneDx Holdings faces a securities class action after its stock fell sharply following a weak Q1 2026 report. The complaint centers on the company’s acquisition of Fabric Genomics and alleges that GeneDx overstated the value and durability of that business. GeneDx also took a large impairment charge tied to Fabric Genomics, which the filing says accounted for most of the cash paid a year earlier. The article highlights missed revenue expectations, a weaker product mix, and a cut to 2026 guidance. The situation underscores how quickly a software-enabled diagnostics acquisition can turn into a financial and legal issue.

▦ Linked Companies

Fabric Genomics

$1M to $5M